作为非酒精性脂肪性肝病的潜在治疗方法,他类药物:使用蛋白质-蛋白质相互作用网络分析来向脱
Ali Mahmoudi1,2, Alexandra E Butler3, Alexander N Orekhov4,5
1Student Research Committee, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Current medicinal chemistry
|August 30, 2023
概括
与其他他类药物相比,simvastatin对与非酒精性脂肪性肝病 (NAFLD) 相关的基因的影响最大. 这项研究使用生物信息学来分析他类药物对NAFLD进展基因的影响.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 药物基因组学 药物基因组学
- 生物信息学是一种生物信息学.
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 的特征是肝细胞中过度积累的甘油三.
- 许多基因有助于NAFLD的发展和进展.
- 类药物是常见的降脂药物,可能对NAFLD相关基因产生影响.
研究的目的:
- 使用生物信息学研究他类药物对参与非酒精性脂肪肝疾病 (NAFLD) 进展的基因的潜在影响.
- 识别可能影响NAFLD病变的特定他类药物及其相关基因.
主要方法:
- 利用基因药物和基因疾病数据库来识别他类药物和NAFLD之间的蛋白质相互作用.
- 构建了一个蛋白质-蛋白质相互作用 (PPI) 网络来识别枢纽基因,并使用分子复杂检测 (MCODE) 来检测NAFLD相关的基因集群.
- 在他类药物和NAFLD基因之间共享的蛋白质标上进行了KEGG通路和基因本体学丰富分析.
主要成果:
- 在他类药物和NAFLD相关基因之间确定了24个共享的蛋白质标.
- 富化分析揭示了参与细胞因子-细胞因子受体相互作用,脂肪因子,PPAR,TNF和AMPK信号通路,以及脂质代谢和炎症反应.
- 西姆瓦斯塔丁成为与NAFLD相关基因和枢纽基因最强烈相关的他类药物,包括PPARA,SREBF1和ADIPOQ.
结论:
- 在分析的他类药物中,simvastatin表现出与NAFLD相关基因的最显著关联.
- 这些发现表明,通过对特定分子通路和基因的影响,simvastatin在管理NAFLD方面具有潜在的治疗作用.
相关概念视频
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
697
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
697
Protein Networks
4.0K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.0K
Protein-protein Interfaces
12.5K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
12.5K
Hepatic Drug Clearance: Effect of Protein Binding
241
Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
241
Cholesterol: Significance and Regulation
581
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
581


